Clinical

Dataset Information

0

Triplet rechallenge of BEACON regimen for RAS wild-type and BRAF V600E mutant metastatic colorectal cancer


ABSTRACT: Interventions: Encorafenib 300 mg once daily Binimetinib 45 mg twice daily Cetuximab 400 mg/m^2 Day 1, 250 mg/m^2 Day 8, 15, 22 (250 mg/m^2 from Cycle 2 later) These treatments are repeated every 28 days in one cycle. Primary outcome(s): Objective Response Rate (ORR) as determined by the site-investigator Study Design: single arm study, open(masking not used), uncontrolled control, single assignment, treatment purpose

DISEASE(S): Unresectable, Advanced Or Recurrent Colorectal Cancer With Ras Wild-type And Braf V600e Mutation

PROVIDER: 2614542 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2614541 | ecrin-mdr-crc
| 2646999 | ecrin-mdr-crc
2023-12-12 | PRJEB70957 | EVA
2022-05-04 | PXD033655 |
2013-07-23 | E-GEOD-39606 | biostudies-arrayexpress
| 2312809 | ecrin-mdr-crc
| 2615453 | ecrin-mdr-crc
| 2745961 | ecrin-mdr-crc
| 2227110 | ecrin-mdr-crc
2024-02-27 | PXD040124 | JPOST Repository